V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003960 | 320005108 | 1.68 | 78.7 | Palliative (P) | 2014-09-28 | 2014-09-29 | Carboplatin + Etoposide iv&po | 02 | N | 320009996 | CETUXIMAB |
| 320003961 | 320002425 | 0 | 52.3 | Palliative (P) | 2016-11-11 | 2016-11-16 | Capecitabine + Cisplatin | 02 | N | 320010062 | CISPLATIN + GEMCITABINE |
| 320003962 | 320002426 | 1.57 | 62.4 | Disease modification (D) | 2015-02-07 | 2015-02-07 | CAPECITABINE + CARBOPLATIN + Cetuximab | 02 | null | 320010149 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003963 | 320002427 | 1.58 | null | Palliative (P) | 2018-11-13 | 2018-11-17 | CISPLATIN + GEMCITABINE | N | null | 320010172 | CETUXIMAB + CISPLATIN + FU |
| 320003964 | 320002428 | 1.5 | 77.1 | Neo-adjuvant (N) | null | 2017-04-06 | Bevacizumab+Carbo+Pacliaxel | 02 | null | 320010386 | CAPECITABINE + OXALIPLATIN |
| 320003965 | 320005109 | null | null | Palliative (P) | 2018-07-25 | 2018-08-04 | Bevacizumab 7.5mg/kg | null | null | 320010455 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320003966 | 320002429 | null | 46.5 | Palliative (P) | 2015-01-06 | 2015-01-06 | Cetuximab + Radiotherapy Load | Y | N | 320010500 | BLEOMYCIN |
| 320003967 | 320002430 | 1.66 | 98.2 | Palliative (P) | null | 2018-02-17 | PACLITAXEL | 02 | N | 320010514 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003968 | 320002430 | 1.74 | 104.4 | null | 2017-04-14 | 2017-04-15 | ECX | 02 | null | 320010514 | CARBOPLATIN + RT |
| 320003969 | 320002430 | null | 58.2 | Curative (C) | 2017-09-13 | 2017-09-21 | Carbo F | Y | Y | 320010514 | CISPLATIN + GEMCITABINE |
| 320003970 | 320002430 | 1.62 | 49.8 | Palliative (P) | 2015-01-20 | 2015-02-04 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320010514 | CISPLATIN + GEMCITABINE |
| 320003971 | 320002430 | 1.79 | 49.6 | Palliative (P) | 2017-07-07 | 2017-07-19 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | null | 320010514 | CAPECITABINE + CARBOPLATIN |
| 320003972 | 320002431 | 1.81 | 57.7 | Curative (C) | 2015-09-06 | 2015-10-06 | Sunitinib | N | N | 320010670 | CARBO + FLUOROURACIL |
| 320003973 | 320002432 | 1.87 | 85 | Palliative (P) | 2018-10-25 | 2018-11-06 | BENDAMUSTINE + RITUXIMAB | 2 | N | 320010694 | CETUXIMAB + RT |
| 320003974 | 320002433 | 1.65 | 75 | Neo-adjuvant (N) | null | 2016-07-11 | Carboplatin + Etoposide IV 3 day | null | null | 320011018 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320003975 | 320002433 | 0 | 52 | Palliative (P) | 2016-02-03 | 2016-02-15 | Cisplatin + Fluorouracil + RT 5day | 2 | N | 320011018 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320003976 | 320002434 | 1.7 | 87 | Palliative (P) | 2014-04-05 | 2014-04-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320011108 | CETUXIMAB |
| 320003977 | 320002435 | null | null | Disease modification (D) | 2015-02-27 | 2015-02-27 | PEMBROLIZUMAB | N | null | 320011291 | OXALIPLATIN + MDG |
| 320003978 | 320002436 | 1.79 | 80 | Palliative (P) | 2016-12-16 | 2016-12-30 | PMB | N | N | 320011408 | CARBOPLATIN + ETOPOSIDE |
| 320003979 | 320005112 | 1.75 | 84.5 | Disease modification (D) | 2016-12-23 | 2017-01-06 | LANREOTIDE | N | N | 320011625 | CARBOPLATIN + RT |
| 320003980 | 320002437 | null | null | Palliative (P) | 2014-08-30 | 2014-12-07 | CTD | 02 | N | 320011851 | CISPLATIN + FLUOROURACIL + RT |
| 320003981 | 320002438 | 1.65 | 63.3 | Palliative (P) | 2016-04-01 | 2016-04-07 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320011933 | ICON8B TRIAL |
| 320003982 | 320002439 | null | 75.5 | Palliative (P) | 2017-10-17 | 2017-10-18 | IVADo | 2 | N | 320011994 | CISPLATIN + PEMETREXED |
| 320003983 | 320002440 | null | 92 | Palliative (P) | 2017-08-09 | 2017-08-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320012088 | CISPLATIN + GEMCITABINE |
| 320003984 | 320005113 | 1.6 | 63 | Not known (9) | 2015-12-23 | 2015-12-28 | Temozolomide + RT | N | N | 320012116 | CETUXIMAB + CISPLATIN + FU |
| 320003985 | 320002441 | 1.66 | null | Palliative (P) | 2016-07-23 | 2016-07-29 | Bevacizumab + Irinotecan + MdG | Y | N | 320012126 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003986 | 320002442 | 1.51 | 45.2 | Palliative (P) | 2016-09-04 | 2016-09-10 | ICON8 TRIAL | N | N | 320012129 | POUT TRIAL |
| 320003987 | 320002443 | 1.6 | 64.2 | Curative (C) | 2017-02-21 | 2017-03-02 | CARBOPLATIN + FLUOROURACIL | 2 | N | 320012147 | BLEOMYCIN + CISPLATIN + MTOMYCIN |
| 320003988 | 320002444 | 1.69 | 42 | Neo-adjuvant (N) | null | 2013-12-07 | Cisplatin+Gemcitabine (gallbladder) | null | null | 320012148 | PACLITAXEL |
| 320003989 | 320002445 | null | 51.65 | Curative (C) | 2017-09-04 | 2017-09-07 | Carboplatin + Etoposide IV 3 day | N | Y | 320012179 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320003990 | 320002446 | 1.53 | 54 | Palliative (P) | 2017-06-02 | 2017-06-16 | Cetuximab + Radiotherapy Load | null | N | 320012181 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003991 | 320002446 | null | 87 | Palliative (P) | null | 2018-10-16 | Cetuximab + CISPLATIN + FLUOROURACIL | null | null | 320012181 | CISPLATIN + GEMCITABINE |
| 320003992 | 320002447 | 1.59 | 64.2 | Palliative (P) | 2017-09-16 | 2017-09-29 | BCG Intravesical | N | N | 320012197 | TRIAL |
| 320003993 | 320002448 | null | 19.5 | Curative (C) | 2018-01-09 | 2018-01-23 | TIP | null | null | 320012214 | CARBO + GEFITINIB + PEMETREXED |
| 320003994 | 320002448 | 1.69 | 79.7 | Palliative (P) | 2017-07-24 | 2017-07-24 | EOX | N | N | 320012214 | OXALIPLATIN + MDG |
| 320003995 | 320002449 | 1.72 | null | Curative (C) | null | 2018-11-17 | Cetuximab + Radiotherapy Maint | N | N | 320012343 | CISPLATIN + GEMCITABINE |
| 320003996 | 320002450 | 1.6 | 67.2 | Neo-adjuvant (N) | 2016-05-11 | 2016-05-12 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 320012406 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003997 | 320002451 | 1.72 | 56 | Palliative (P) | 2018-12-02 | 2018-12-16 | Cisplatin + Doxorubicin | N | N | 320012420 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003998 | 320002452 | 2 | 88.2 | Palliative (P) | 2017-04-08 | 2017-04-20 | CISPLATIN + ETOPOSIDE | 02 | N | 320012447 | CARBO + FLUOROURACIL |
| 320003999 | 320002453 | 1.87 | 77 | Neo-adjuvant (N) | 2014-07-26 | 2014-08-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 320012567 | TEMOZOLOMIDE |
| 320004000 | 320002453 | 1.68 | null | Curative (C) | 2016-12-30 | 2017-01-22 | PACLITAXEL | N | Y | 320012567 | CETUXIMAB |
| 320004001 | 320002453 | 1.6 | 68.6 | Adjuvant (A) | 2013-07-01 | 2013-07-20 | Dacarbazine | 02 | Y | 320012567 | CISPLATIN + ETOPOSIDE |
| 320004002 | 320006971 | 1.64 | 67.5 | Curative (C) | 2017-11-04 | 2017-11-19 | CAPECITABINE + CARBOPLATIN | 02 | Y | 320012774 | CETUXIMAB + RT |
| 320004003 | 320002454 | 1.84 | 82.4 | Palliative (P) | null | 2016-07-14 | Cabazitaxel | Y | N | 320012807 | CISPLATIN + PEMETREXED |
| 320004004 | 320002454 | 1.65 | 57.7 | Neo-adjuvant (N) | 2014-08-01 | 2014-08-11 | ECX | 02 | N | 320012807 | CISPLATIN + GEMCITABINE |
| 320004005 | 320002455 | 1.74 | 87 | Palliative (P) | 2014-05-26 | 2014-06-02 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 320012874 | CARBO + FLUOROURACIL |
| 320004006 | 320002456 | 1.68 | 97.4 | null | 2015-07-17 | 2015-08-13 | CISPLATIN + FLUOROURACIL + RT | N | N | 320012878 | CAPECITABINE + CARBOPLATIN |
| 320004007 | 320002457 | 1.6 | null | Adjuvant (A) | 2014-02-14 | 2014-02-14 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320012884 | CETUXIMAB + RT |
| 320004008 | 320002458 | 1.6 | 55.2 | null | null | 2015-04-19 | Carboplatin + Etoposide iv&po | null | null | 320012915 | ICON8B TRIAL |
| 320004009 | 320002459 | 1.58 | 83 | Palliative (P) | 2014-04-18 | 2014-04-18 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 320012960 | BEVACIZUMAB |